✦ LIBER ✦

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

✍ Scribed by Calabrò, Luana; Morra, Aldo; Fonsatti, Ester; Cutaia, Ornella; Amato, Giovanni; Giannarelli, Diana; Di Giacomo, Anna Maria; Danielli, Riccardo; Altomonte, Maresa; Mutti, Luciano; Maio, Michele

Book ID: 122755327
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 431 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70381-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ipilimumab and fotemustine in patients w

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

✍ Anna Maria Di Giacomo; Paolo A Ascierto; Lorenzo Pilla; Mario Santinami; Pier Fr 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 177 KB

Single-arm, open label study of pemetrex

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

✍ Obasaju, Coleman K.; Ye, Zhishen; Wozniak, Antoinette J.; Belani, Chandra P.; Ke 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 330 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Telaprevir for HIV/Hepatitis C Virus-Coi

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

✍ Cotte, L.; Braun, J.; Lascoux-Combe, C.; Vincent, C.; Valantin, M.-A.; Sogni, P. 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 525 KB

Thalidomide versus active supportive car

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

✍ Buikhuisen, Wieneke A; Burgers, Jacobus A; Vincent, Andrew D; Korse, Catharina M 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 363 KB

CH5424802 (RO5424802) for patients with

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study

✍ Seto, Takashi; Kiura, Katsuyuki; Nishio, Makoto; Nakagawa, Kazuhiko; Maemondo, M 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 282 KB